课题基金 / 基金详情

B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis

B. anthracis Peptidoglycan as a Pro-inflammatory Agent in Anthrax Pathogenesis
B. 炭疽杆菌肽聚糖作为炭疽发病机制中的促炎剂
批准号:
7695608
负责人:
Kenneth Mark Coggeshall
金额:
$28.55万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-09-01 至 2014-08-31

项目摘要

项目成果

Kenneth Mark Coggeshall的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Much of the work on inhalation anthrax has exclusively focused on the exotoxins. Our recent studies ndicate that the peptidoglycan component of the B. anthracis cell wall induces the production of nflammatory cytokines and chemokines. The production of the cytokines and chemokines is exclusively from peripheral blood monocytes; lymphocytes and neutrophils do not respond. We have preliminary and on-going structural work to chemically characterize B. anthracis peptidoglycan. We have novel tools to identify the currently unknown extracellular receptor for Gram-positive peptidoglycan and to understand the signaling events induced by the receptor and causing the changes in monocyte biology. Additionally, we have new data indicating that peptidoglycan induces monocyte apoptosis in a subpopulation distinct from the monocytes producing inflammatory cytokines. We present an experimental plan to identify the mechanism of peptidoglycan-triggered apoptosis. The monocyte apoptosis might contribute to the high mortality of B. anthracis and possibly of other Gram-positive pathogens by eliminating an important component of the innate immune system. We will test this possibility by challenging rodents and non-human primates with B. anthracis peptidoglycan and measuring monocyte levels.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
Molecular and Immunologic Analysis of the Pathobiology of Human Anthrax
Administrative Core
Administrative Core
海外基金